Supplemental Figure 1 from Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors
Authors:
- Matthew D. HellmannMHMatthew D. Hellmann
- Nicoletta BiviNBNicoletta Bivi
- Boris CalderonBCBoris Calderon
- Toshio ShimizuTSToshio Shimizu
- Brant DelafontaineBDBrant Delafontaine
- Zhuqing Tina LiuZLZhuqing Tina Liu
- Anna M. SzpurkaASAnna M. Szpurka
- Victoria CopelandVCVictoria Copeland
- F. Stephen HodiFHF. Stephen Hodi
- Sylvie RotteySRSylvie Rottey
- Philippe AftimosPAPhilippe Aftimos
- Yongzhe PiaoYPYongzhe Piao
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)